The safety profile of cyclophosphamide in multiple sclerosis therapy.
about
Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents.Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.Promotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis.Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice.Immune mediated diseases and immune modulation in the neurocritical care unitThe Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis.Chemoprotective potential of Coccinia indica against cyclophosphamide-induced toxicityHuman bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity.Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation.An update on multiple sclerosis in children: diagnosis, therapies, and prospects for the future.Oral administration of tea saponins to relive oxidative stress and immune suppression in chickens.Gallic acid protects against cyclophosphamide-induced toxicity in testis and epididymis of rats.Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity-Report of a Case and Review of the Literature.Cardioprotective Effect of Selenium Against Cyclophosphamide-Induced Cardiotoxicity in Rats.Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of Ellagic acid.Atorvastatin mitigates cyclophosphamide-induced hepatotoxicity via suppression of oxidative stress and apoptosis in rat model
P2860
Q33380516-D95FC82C-BB99-4B60-9E33-62FF5CB31F54Q34409273-CDBE5571-1562-421C-AF37-9D2475F19F8FQ34828914-2DB532ED-82B2-47DA-A381-F833C166E502Q35602805-D3F553B2-E074-4C13-B9F2-49DD53DC6B06Q35729575-2348EE4D-7119-4FF3-A438-5D7C2E681808Q36062456-FFDECAA9-6462-4739-922D-86CAD2684BEEQ37143576-F3D20461-ED7E-451D-ACCF-CA2D77A1068EQ37222490-E1E3C814-C6F6-46BB-ACDE-6147B2A2A1F6Q37253314-B7508F83-BA64-4E78-B231-F11CA64AE4BCQ37416463-98C02481-8ADC-4B63-BFF5-3C2FF83E3291Q38068541-8B7C2689-F59E-49E7-82BF-5A76EECED701Q38652593-52B49271-D0FB-4A07-B94A-C8680137901FQ40152597-B79C7F25-147A-4252-BE50-99BDF57F30DBQ46177482-8DBC7909-09C6-4EEE-AE5D-187A920D9F89Q47106449-1851B8C2-A843-4C03-9D4E-4C7A4EB2329EQ48318079-89CA87CD-5D07-447F-B1AF-4A642AFE44B0Q53189227-4BF4CFB1-3991-4725-8EE4-8C4DE570F29FQ57062313-04680D96-9DD3-47B0-89DA-119B298B25C9
P2860
The safety profile of cyclophosphamide in multiple sclerosis therapy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The safety profile of cyclophosphamide in multiple sclerosis therapy.
@ast
The safety profile of cyclophosphamide in multiple sclerosis therapy.
@en
type
label
The safety profile of cyclophosphamide in multiple sclerosis therapy.
@ast
The safety profile of cyclophosphamide in multiple sclerosis therapy.
@en
prefLabel
The safety profile of cyclophosphamide in multiple sclerosis therapy.
@ast
The safety profile of cyclophosphamide in multiple sclerosis therapy.
@en
P2093
P2860
P356
P1476
The safety profile of cyclophosphamide in multiple sclerosis therapy.
@en
P2093
Luciano Rinaldi
Massimiliano Calabrese
Paola Perini
Paolo Gallo
P2860
P304
P356
10.1517/14740338.6.2.183
P407
P577
2007-03-01T00:00:00Z